Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Skip to main content

Oxford has fantastic strength in basic immunology research.

basic immunology

Oxford has a wonderful history in immunology research, including determining the structure of antibodies and uncovering the function of lymphocytes. The foundation for understanding human immune disorders and infection is built on the knowledge gained from basic research. 

 

DEPARTMENTS IN THIS THEME

People in this Theme

What's new

New therapeutic target identified in spondyloarthritis

A new study published in Nature Communications identifies a key driver of joint and intestinal inflammation that could lead to future treatment of the chronic inflammatory disease.

Researchers identify link in the treatment of inflammatory bowel disease (IBD)

A new study published in the Journal of Experimental Medicine reveals how IL-10 and PGE2 work together to prevent inflammatory tissue damage and maintain a healthy gut balance

Dissecting TNF signalling in inflammatory disease

New research from Dr Richard Williams’ group at the Kennedy Institute suggests a route for the development of more selective – and effective – therapies for immune-mediated inflammatory disease.

Naturally occurring compound spermidine boosts vaccine responses in old mice

A new study by Kennedy Institute's Professor Katja Simon, and colleagues published in Molecular Cell shows that spermidine, a naturally occurring metabolite found in most human cell types, boosts antibody production in both old mice and immune cells from the elderly.